Home / Inspections / 1122821

FDA Inspection 1122821 — Southern Illinois Healthcare

Southern Illinois Healthcare — FEI 1470247

The FDA completed an inspection of Southern Illinois Healthcare on February 20, 2020 in Herrin, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Herrin, IL (United States)

Facility

Other inspections at this facility

  • 985195 (NAI Mon Sep 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 814565 (NAI Thu Jan 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 705728 (NAI Mon Jan 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources